Effects of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality: A Comprehensive Network Meta-analysis

被引：0
|
作者：
Tang, Huilin
Fang, Zhenwei
Wang, Tiansheng
Song, Yiqing
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1386-P
引用
收藏
页码：A363 / A363
页数：1
相关论文
共 50 条
  • [1] The Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors on Cardiovascular Outcomes and All-Cause Mortality in Patients With Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
    Sinha, Tanya
    Khilji, Faria
    Laraib, Fnu
    Fatima, Farhana
    Kaur, Mandeep
    Chaudhari, Sandipkumar S.
    Agbor, Divine Besong Arrey
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [2] Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus
    Tang, Huilin
    Fang, Zhenwei
    Wang, Tiansheng
    Cui, Wei
    Zhai, Suodi
    Song, Yiqing
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (11): : 1774 - 1780
  • [3] Sodium-Glucose Cotransporter 2 Inhibitors, All-Cause Mortality, and Cardiovascular Outcomes in Adults with Type 2 Diabetes: A Bayesian Meta-Analysis and Meta-Regression
    Odutayo, Ayodele
    da Costa, Bruno R.
    Pereira, Tiago V.
    Garg, Vinay
    Iskander, Samir
    Roble, Fatimah
    Lalji, Rahim
    Hincapie, Cesar A.
    Akingbade, Aquila
    Rodrigues, Myanca
    Agarwal, Arnav
    Lawendy, Bishoy
    Saadat, Pakeezah
    Udell, Jacob A.
    Cosentino, Francesco
    Grant, Peter J.
    Verma, Subodh
    Juni, Peter
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (18):
  • [4] Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials
    Kani, R.
    Watanabe, A.
    Miyamoto, Y.
    Kuno, T.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [5] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature
    Mani, Sweatha
    Balasubramanian, Abirami
    Veluswami, Keerthana
    Rao, Sudipta
    Aggarwal, Shailesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [6] THE EFFICACY AND SAFETY OF SODIUM-GLUCOSE COTRANSPORTER 2 (SGLT2) INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Alves, C.
    Penedones, A.
    Mendes, D.
    Batel Marques, F.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E123 - E124
  • [7] Role of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors
    Lusk, Kathleen A.
    Barnes, Nicole E.
    US PHARMACIST, 2016, 41 (11) : 38 - 42
  • [8] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Stroke
    Kimura, Genjiro
    CIRCULATION JOURNAL, 2017, 81 (06) : 898 - 898
  • [9] Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
    Kalra S.
    Cardiology and Therapy, 2016, 5 (2) : 161 - 168
  • [10] SGLT2 Inhibitors and All-Cause Mortality
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (04)
12345